Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-21
1999-10-12
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 32, 514278, 514411, 424489, A01N 4344
Patent
active
059655712
ABSTRACT:
Parkinson's disease can be treated with an at least one cholinesterase inhibitor. The cholinesterase inhibitor has been found to alleviate both any symptoms of dementia as well as to reduce rigidity and improve motor function.
REFERENCES:
patent: 4948807 (1990-08-01), Rosin et al.
patent: 5585378 (1996-12-01), Boar et al.
patent: 5668117 (1997-09-01), Shapiro
Channavajjala Lakshmi
New York University
Page Thurman K.
LandOfFree
Cholinesterase inhibitors for treatment of Parkinson's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholinesterase inhibitors for treatment of Parkinson's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholinesterase inhibitors for treatment of Parkinson's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652775